Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
Aptevo Therapeutics Inc (NASDAQ: APVO) closed the day trading at $1.63 up 1.87% from the previous closing price of $1.6. In other words, the price has increased by $1.87 from its previous closing price. On the day, 1.49 million shares were traded. APVO stock price reached its highest trading level at $1.64 during the session, while it also had its lowest trading level at $1.53.
Ratios:
For a better understanding of APVO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.27 and its Current Ratio is at 2.27. In the meantime, Its Debt-to-Equity ratio is 0.65 whereas as Long-Term Debt/Eq ratio is at 0.65.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APVO now has a Market Capitalization of 22508614 and an Enterprise Value of 158306.
Stock Price History:
The Beta on a monthly basis for APVO is 5.88, which has changed by -0.985789 over the last 52 weeks, in comparison to a change of 0.13724327 over the same period for the S&P500. Over the past 52 weeks, APVO has reached a high of $381.10, while it has fallen to a 52-week low of $1.32. The 50-Day Moving Average of the stock is -6.36%, while the 200-Day Moving Average is calculated to be -93.95%.
Shares Statistics:
Over the past 3-months, APVO traded about 5.38M shares per day on average, while over the past 10 days, APVO traded about 8022380 shares per day. A total of 13.81M shares are outstanding, with a floating share count of 13.81M. Insiders hold about 0.00% of the company’s shares, while institutions hold 11.06% stake in the company. Shares short for APVO as of 1759190400 were 1392722 with a Short Ratio of 0.26, compared to 1756425600 on 102203. Therefore, it implies a Short% of Shares Outstanding of 1392722 and a Short% of Float of 10.09.
Earnings Estimates
Aptevo Therapeutics Inc (APVO) is currently under the scrutiny of 1.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$1.9, with high estimates of -$1.9 and low estimates of -$1.9.
Analysts are recommending an EPS of between -$14.18 and -$14.18 for the fiscal current year, implying an average EPS of -$14.18. EPS for the following year is -$7.42, with 1.0 analysts recommending between -$7.42 and -$7.42.
